Search research articles
Contact Us
Filters
Showing results (831-840 of 853) with videos related to
Page
of 86
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer
Bradley J Monk, Thomas J Herzog, Stanley B Kaye, et al.
BMJ Open Ophthalmology
|
September 20, 2023
Preoperative surgeon evaluation of corneal endothelial status: the Viability Control of Human Endothelial Cells before Keratoplasty (V-CHECK) study protocol
Matteo Airaldi, Yalin Zheng, Francesco Aiello, et al.
Science Translational Medicine
|
June 3, 2011
A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinoma
Natsuko Suwaki, Elsa Vanhecke, Katelyn M Atkins, et al.
Cancer Research
|
April 3, 2009
Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer
Gerhardt Attard, Joost F Swennenhuis, David Olmos, et al.
British Journal of Cancer
|
December 4, 1998
Chemotherapy for ovarian cancer--a consensus statement on standard practice
M Adams, A H Calvert, J Carmichael, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2001
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group
K Fizazi, S Tjulandin, R Salvioni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2009
PPM1D is a potential therapeutic target in ovarian clear cell carcinomas
David S P Tan, Maryou B K Lambros, Sydonia Rayter, et al.
Nature Reviews. Cancer
|
September 24, 2011
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan, Jermaine I Coward, Robert C Bast, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2013
Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study
Joo Ern Ang, Charlie Gourley, C Bethan Powell, et al.
EMBO Molecular Medicine
|
March 12, 2021
Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer
Michal M Hoppe, Patrick Jaynes, Joanna D Wardyn, et al.
Page
of 86
Search research articles
Search
Showing results (831-840 of 853) with videos related to
Sort By:
Page
of 86
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer
Bradley J Monk, Thomas J Herzog, Stanley B Kaye, et al.
BMJ Open Ophthalmology
|
September 20, 2023
Preoperative surgeon evaluation of corneal endothelial status: the Viability Control of Human Endothelial Cells before Keratoplasty (V-CHECK) study protocol
Matteo Airaldi, Yalin Zheng, Francesco Aiello, et al.
Science Translational Medicine
|
June 3, 2011
A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinoma
Natsuko Suwaki, Elsa Vanhecke, Katelyn M Atkins, et al.
Cancer Research
|
April 3, 2009
Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer
Gerhardt Attard, Joost F Swennenhuis, David Olmos, et al.
British Journal of Cancer
|
December 4, 1998
Chemotherapy for ovarian cancer--a consensus statement on standard practice
M Adams, A H Calvert, J Carmichael, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2001
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group
K Fizazi, S Tjulandin, R Salvioni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2009
PPM1D is a potential therapeutic target in ovarian clear cell carcinomas
David S P Tan, Maryou B K Lambros, Sydonia Rayter, et al.
Nature Reviews. Cancer
|
September 24, 2011
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan, Jermaine I Coward, Robert C Bast, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2013
Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study
Joo Ern Ang, Charlie Gourley, C Bethan Powell, et al.
EMBO Molecular Medicine
|
March 12, 2021
Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer
Michal M Hoppe, Patrick Jaynes, Joanna D Wardyn, et al.
Page
of 86